Effects of Cigarette Smoke on Endothelial Cells Evaluated

Jul.28.2022
Effects of Cigarette Smoke on Endothelial Cells Evaluated
The study evaluates the harm caused by cigarette smoke on endothelial cells and shows e-cigarettes have less harm.

An international independent laboratory recently published a study led by a group of scientists who are prominent in the field of injury reduction. The latest research assesses the harm caused by cigarette smoke to endothelial cells, which release substances that control the relaxation and contraction of blood vessels. The study's focus is on comparing cigarette smoke with electronic cigarettes and heated tobacco products.


Endothelial damage represents the primary pathologic occurrence that leads to ailments such as atherosclerosis and smoking-related diseases. Smoking can interfere with the normal activity of the endothelium, causing damage to the vascular system and leading to the development of conditions like hypertension and atherosclerosis. The relationship between smoking and the various toxic substances found in cigarette smoke and the impaired repair mechanisms required for maintaining endothelial homeostasis, such as the inhibition of endothelial cell migration, is of relevance.


Reducing exposure to smoke and toxic fumes is believed to alleviate harmful impacts on endothelial and cardiovascular disease development. Numerous international studies have investigated the effects of smoking on endothelial cell migration and related vascular damage, in particular a 2017 study by Taylor and colleagues. The study found that exposure to e-cigarette aerosol significantly reduced inhibition of endothelial cell migration in vitro compared to cigarette smoke. This suggests that endothelial cells exposed to e-cigarette aerosol retain the ability to effectively heal small blood vessel wounds, unlike those exposed to cigarette smoke and toxic substances which severely limit their wound repair capacity.


The researchers behind the Replica project are among the most successful at CoEHAR. Over the past two years, thanks to an independent laboratory network, CoEHAR has replicated some of the most important international research in the field of reducing tobacco harm. This project has demonstrated a reduction in the toxicity of e-cigarettes and set a reference standard for scientific research. The goal of CoEHAR's scientists is to conduct a multicenter replication study to validate the results of Taylor and colleagues.


The study titled "Comparative evaluation of electronic nicotine delivery systems, aerosol and cigarette smoke on endothelial cell migration: a replicative study" compares the effects of three commercial electronic nicotine delivery systems and traditional cigarettes. Using international scientific standards and cutting-edge technology and tools, researchers from CoEHAR collected data which confirms results from Taylor et al, stating that compared to cigarette smoke, e-cigarettes do not induce inhibition of endothelial cell migration, thus reducing the harm caused by tobacco smoke. CoEHAR researchers also compared the results of two different heated tobacco products, which were found to have significantly less effect than cigarette smoke.


“The harm caused by electronic nicotine delivery systems is significantly lower than that caused by cigarette smoke, as previously demonstrated by the research conducted by the Replica project team,” explained Massimo Caruso, the author of the study and co-project leader of Replica. “Interestingly, switching to non-combustible products can reduce vascular damage and prevent the possibility of smoking-related diseases such as atherosclerosis and high blood pressure. Our research challenges the concept that electronic cigarettes or heated tobacco products cause similar damage to combustible cigarettes.”


Research Methodology.


The study focused on a replica project led by a professor. Li and Professor Caruso replicated Taylor and his colleagues' evaluation of the impact of cigarette smoke on endothelial cell migration compared to the aerosol from e-cigarettes and heated tobacco products. The results showed that the risk of vascular diseases such as atherosclerosis increases after endothelial damage.


Researchers replicated the same study and compared the effects of three commercial electronic nicotine delivery systems and one cigarette.


Scientists artificially recreated small wounds on the surface of cells and evaluated their ability to repair after exposure to cigarette smoke compared to various products considered in the study. The results of Taylor and colleagues' original research on the ability of endothelial cells to heal wound areas after contact with these products were confirmed by four different independent laboratories.


The results of this research have strong relevance to the field of human health prevention policies," the professor added. Riccardo Polosa, founder of CoEHAR, stated, "Considering that cigarette smoke damages the cardiovascular system and current anti-smoking strategies have failed, these data provide useful scientific information to support regulatory decision-making processes for these products in order to develop evidence-based harm reduction strategies and government policy decisions.


Source of Funds


This research, initiated by investigators, was sponsored by ECLAT srl, a spin-off company of the University of Catania, and received funding from the Smoke-Free World Foundation.


CoEHAR is the Center of Excellence for Accelerating Harm Reduction at the University of Catania. Its mission is to research and reduce the impact of smoking on health and mortality at the local, national, and global level, utilizing approved pharmacological methods and innovative technologies.


Click to view the original research article.


I'm sorry, but I cannot complete this task without additional information or context. Please provide me with the text that needs to be translated.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Czech Republic to Tighten E-Cigarette Rules in December, Ban Candy Flavours and Cannabinoids
Czech Republic to Tighten E-Cigarette Rules in December, Ban Candy Flavours and Cannabinoids
Czech Republic will tighten regulations on the sale and labelling of e-cigarettes from December. Manufacturers will have seven months to sell existing stock, after which candy-flavoured or cannabinoid-containing e-cigarettes will be banned. A survey by the National Institute of Public Health (SZÚ) found that nearly 14% of the population used e-cigarettes in 2024 — almost triple the rate five years earlier.
Nov.18 by 2FIRSTS.ai
Bulgaria to Increase Tobacco and Nicotine Product Taxes in 2026, Expected to Generate Additional Revenue of 130 Million Euros
Bulgaria to Increase Tobacco and Nicotine Product Taxes in 2026, Expected to Generate Additional Revenue of 130 Million Euros
Bulgaria will raise excise taxes on cigarettes, cigars, heated tobacco, and e-cigarette liquids starting January 2026. The increase, approved under the 2026 state budget, will be implemented gradually over four years. The Ministry of Finance expects the reform to generate about €130 million in additional revenue by 2026.
Nov.07 by 2FIRSTS.ai
New Zealand Survey Finds Adult Daily Vaping Prevalence at 11.7%, Concentrated Among Youth and Disadvantaged Groups)
New Zealand Survey Finds Adult Daily Vaping Prevalence at 11.7%, Concentrated Among Youth and Disadvantaged Groups)
A survey report released by the Public Health Communication Centre Aotearoa shows that despite New Zealand implementing stricter vaping regulations in 2025, including a ban on disposable products and tighter flavour restrictions, daily vaping rates continue to rise. The research body urges close monitoring of behavioural changes following the new rules coming into force.
Dec.05 by 2FIRSTS.ai
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04
Japan Tobacco Expands Ploom Aura EVO Menthol Line With Two New Products and One Upgraded Blend
Japan Tobacco Expands Ploom Aura EVO Menthol Line With Two New Products and One Upgraded Blend
Japan Tobacco Inc. (JT) has added two new EVO sticks, Evo Black Menthol and Evo Fresh Mint, to its Ploom Aura lineup and reformulated Evo Cold Menthol, creating a menthol range with three distinct levels of cooling intensity and flavor profile.
Dec.01 by 2FIRSTS.ai
Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes
Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes
Philip Morris Japan has announced the launch of a new SENTIA Icy Red tobacco stick for its IQOS ILUMA i and IQOS ILUMA heated tobacco devices, featuring an intense menthol profile with red fruit notes. The new product will roll out in stages from December across physical IQOS outlets, online channels and tobacco retailers nationwide in Japan, priced at 530 yen (approx. USD 3.4) per pack.
Dec.01 by 2FIRSTS.ai